Visualizing novel concepts of cardiovascular calcification

Trends in Cardiovascular Medicine

Volumn 23, Issue 3, 2013, Pages 71-79

  Hjortnaes, Jesper ^a   New, Sophie E P ^a   Aikawa, Elena ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; VASCULAR CELL ADHESION MOLECULE 1;

AGING; AORTA VALVE CALCIFICATION; AORTA VALVE STENOSIS; ARTERY CALCIFICATION; ATHEROSCLEROSIS; CALCIFICATION; CARDIOVASCULAR CALCIFICATION; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL LOSS; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE RELEASE; DISEASE COURSE; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; FAMILIAL HYPERCHOLESTEROLEMIA; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; INFLAMMATION; MINERALIZATION; NANOTECHNOLOGY; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; CALCINOSIS; CARDIOMYOPATHIES; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; MOLECULAR IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR CALCIFICATION;

EID: 84875276069     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.09.003     Document Type: Review

References (79)

1. Abedin M., Tintut Y., Demer L.L. Vascular calcification: mechanisms and clinical ramifications. Arteriosclerosis, Thrombosis, and Vascular Biology 2004, 24:1161-1170.
2. Aikawa E., Aikawa M., Libby P., et al. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation 2009, 119:1785-1794.
3. Aikawa E., Nahrendorf M., Figueiredo J.L., et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 2007, 116:2841-2850.
4. Aikawa E., Nahrendorf M., Sosnovik D., et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 2007, 115:377-386.
5. Aikawa E., Otto C.M. Look more closely at the valve: imaging calcific aortic valve disease. Circulation 2012, 125:9-11.
6. Anderson H.C. Normal and abnormal mineralization in mammals. Transactions - American Society for Artificial Internal Organs 1981, 27:702-708.
7. Anderson H.C. Matrix vesicles and calcification. Current Rheumatology Reports 2003, 5:222-226.
8. Anderson H.C., Stechschulte D.J., Collins D.E., et al. Matrix vesicle biogenesis in vitro by rachitic and normal rat chondrocytes. American Journal of Pathology 1990, 136:391-398.
9. Aronow W.S., Ahn C., Kronzon I., Goldman M.E. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. The American Journal of Cardiology 2001, 88(6):693-695.
10. Beheshti M., Saboury B., Mehta N.N., et al. Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography/computed tomography - a novel concept. Hellenic Journal of Nuclear Medicine 2011, 14:114-120.
11. Bellamy M.F., Pellikka P.A., Klarich K.W., Tajik A.J., Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. Journal of the American College of Cardiology 2002, 40(10):1723-1730.
12. Bobryshev Y.V., Killingsworth M.C., Huynh T.G., Lord R.S., Grabs A.J., Valenzuela S.M. Are calcifying matrix vesicles in atherosclerotic lesions of cellular origin?. Basic Research in Cardiology 2007, 102:133-143.
13. Bostrom K. Proinflammatory vascular calcification. Circulation Research 2005, 96:1219-1220.
14. Boyle J.J., Bowyer D.E., Weissberg P.L., Bennett M.R. Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions. Arteriosclerosis, Thrombosis, and Vascular Biology 2001, 21:1402-1407.
15. Boyle J.J., Weissberg P.L., Bennett M.R. Human macrophage-induced vascular smooth muscle cell apoptosis requires NO enhancement of Fas/Fas-L interactions. Arteriosclerosis, Thrombosis, and Vascular Biology 2002, 22:1624-1630.
16. Butcher J.T., Nerem R.M. Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: effects of steady shear stress. Tissue Engineering 2006, 12:905-915.
17. Chen N.X., O'Neill K.D., Chen X., Moe S.M. Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. Journal of Bone and Mineral Research 2008, 23:1798-1805.
18. Corsten M.F., Bennaghmouch A. Optical characterization of arterial apoptosis. Methods in Molecular Biology 2011, 680:117-129.
19. Cowell S.J., Newby D.E., Prescott R.J., et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. New England Journal of Medicine 2005, 352:2389-2397.
20. Cybulsky M.I., Gimbrone M.A. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991, 251:788-791.
21. Demer L.L., Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation 2008, 117:2938-2948.
22. Dweck M.R., Jones C., Joshi N.V., et al. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation 2012, 125:76-86.
23. Ehara S., Kobayashi Y., Yoshiyama M., et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation 2004, 110:3424-3429.
24. El-Abbadi M., Giachelli C.M. Mechanisms of vascular calcification. Advances in Chronic Kidney Disease 2007, 14:54-66.
25. Folco E.J., Sheikine Y., Rocha V.Z., et al. Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-d-glucose positron emission tomography. Journal of the American College of Cardiology 2011, 58:603-614.
26. Ghaisas N.K., Foley J.B., O'Briain D.S., Crean P., Kelleher D., Walsh M. Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement. Journal of the American College of Cardiology 2000, 36:2257-2262.
27. Gryglewski R.J., Botting R.M., Vane J.R. Mediators produced by the endothelial cell. Hypertension 1988, 12:530-548.
28. Hjortnaes J., Butcher J., Figueiredo J.L., et al. Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. European Heart Journal 2010, 31:1975-1984.
29. Hjortnaes J., Gottlieb D., Figueiredo J.L., et al. Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility study. Tissue Engineering Part C: Methods 2010, 16:597-607.
30. Hyafil F., Messika-Zeitoun D., Burg S., et al. Detection of 18fluoride sodium accumulation by positron emission tomography in calcified stenotic aortic valves. The American Journal of Cardiology 2012, 109:1194-1196.
31. Jaffer F.A., Nahrendorf M., Sosnovik D., Kelly K.A., Aikawa E., Weissleder R. Cellular imaging of inflammation in atherosclerosis using magnetofluorescent nanomaterials. Molecular Imaging 2006, 5:85-92.
32. Johnson R.C., Leopold J.A., Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circulation Research 2006, 99:1044-1059.
33. Kapustin A.N., Davies J.D., Reynolds J.L., et al. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circulation Research 2011, 109:e1-e12.
34. Karnik S.K., Brooke B.S., Bayes-Genis A., et al. A critical role for elastin signaling in vascular morphogenesis and disease. Development 2003, 130:411-423.
35. Kaufmann B.A., Carr C.L., Belcik J.T., et al. Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2010, 30:54-59.
36. Kim K.M. Calcification of matrix vesicles in human aortic valve and aortic media. Federal Proceedings 1976, 35:156-162.
37. Kozloff K.M., Weissleder R., Mahmood U. Noninvasive optical detection of bone mineral. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007, 22:1208-1216.
38. Li R., Mittelstein D., Lee J., et al. A dynamic model of calcific nodule destabilization in response to monocyte- and oxidized lipid-induced matrix metalloproteinases. American Journal of Physiology - Cell Physiology 2012, 302:C658-C665.
39. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480-486.
40. Marui N., Offermann M.K., Swerlick R., et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. Journal of Clinical Investigation 1993, 92:1866-1874.
41. Mohler E.R. Mechanisms of aortic valve calcification. The American Journal of Cardiology 2004, 94:1396-1402. A1396.
42. Moses J.W., Carlier S., Moussa I. Lesion preparation prior to stenting. Reviews in Cardiovascular Medicine 2004, 5(Suppl. 2):S16-21.
43. Muller A.M., Cronen C., Kupferwasser L.I., Oelert H., Muller K.M., Kirkpatrick C.J. Expression of endothelial cell adhesion molecules on heart valves: up-regulation in degeneration as well as acute endocarditis. The Journal of Pathology 2000, 191:54-60.
44. Nadra I., Boccaccini A.R., Philippidis P., et al. Effect of particle size on hydroxyapatite crystal-induced tumor necrosis factor alpha secretion by macrophages. Atherosclerosis 2008, 196:98-105.
45. Nadra I., Mason J.C., Philippidis P., et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification?. Circulation Research 2005, 96:1248-1256.
46. Nahrendorf M., Jaffer F.A., Kelly K.A., et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006, 114:1504-1511.
47. Nakashima Y., Raines E.W., Plump A.S., Breslow J.L., Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arteriosclerosis, Thrombosis, and Vascular Biology 1998, 18:842-851.
48. New S.E., Aikawa E. Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circulation Research 2011, 108:1381-1391.
49. Novaro G.M., Tiong I.Y., Pearce G.L., Lauer M.S., Sprecher D.L., Griffin B.P. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001, 104:2205-2209.
50. Otto C.M. Calcific aortic stenosis - time to look more closely at the valve. New England Journal of Medicine 2008, 359:1395-1398.
51. Otto C.M., Kuusisto J., Reichenbach D.D., Gown A.M., O'Brien K.D. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994, 90:844-853.
52. Parhami F., Basseri B., Hwang J., Tintut Y., Demer L.L. High-density lipoprotein regulates calcification of vascular cells. Circulation Research 2002, 91:570-576.
53. Peacock J.D., Levay A.K., Gillaspie D.B., Tao G., Lincoln J. Reduced sox9 function promotes heart valve calcification phenotypes in vivo. Circulation Research 2010, 106:712-719.
54. Perng J.K., Lee S., Kundu K., et al. Ultrasound imaging of oxidative stress in vivo with chemically-generated gas microbubbles. Annals of Biomedical Engineering 2012.
55. Proudfoot D., Skepper J.N., Hegyi L., Bennett M.R., Shanahan C.M., Weissberg P.L. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circulation Research 2000, 87:1055-1062.
56. Radcliff K., Tang T.B., Lim J., Zhang Z., Abedin M., Demer L.L., et al. Insulin-like growth factor-I regulates proliferation and osteoblastic differentiation of calcifying vascular cells via extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase pathways. Circulation Research 2005, 96:398-400.
57. Rajamannan N.M. Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology. American Journal of Physiology - Heart and Circulatory Physiology 2010, 298:H5-15.
58. Rajamannan N.M., Bonow R.O., Rahimtoola S.H. Calcific aortic stenosis: an update. Nature Clinical Practice Cardiovascular Medicine 2007, 4:254-262.
59. Rajamannan N.M., Evans F.J., Aikawa E., et al. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease - 2011 update. Circulation 2011, 124:1783-1791.
60. Rajamannan N.M., Sangiorgi G., Springett M., et al. Experimental hypercholesterolemia induces apoptosis in the aortic valve. The Journal of Heart Valve Disease 2001, 10:371-374.
61. Rajamannan N.M., Subramaniam M., Springett M., Sebo T.C., Niekrasz M., McConnell J.P., et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 2002, 105:2660-2665.
62. Rattazzi M., Bennett B.J., Bea F., et al. Calcification of advanced atherosclerotic lesions in the innominate arteries of ApoE-deficient mice: potential role of chondrocyte-like cells. Arteriosclerosis Thrombosis and Vascular Biology 2005, 25:1420-1425.
63. Reynolds J.L., Joannides A.J., Skepper J.N., et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. Journal of the American Society of Nephrology 2004, 15:2857-2867.
64. Rossebo A.B., Pedersen T.R., Boman K., et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. New England Journal of Medicine 2008, 359:1343-1356.
65. Saulnier J.M., Hauck M., Fulop T., Wallach J.M. Human aortic elastin from normal individuals and atherosclerotic patients: lipid and cation contents; susceptibility to elastolysis. Clinica Chimica Acta 1991, 200:129-136.
66. Shanahan C.M. Inflammation ushers in calcification: a cycle of damage and protection?. Circulation 2007, 116:2782-2785.
67. Shavelle D.M., Katz R., Takasu J., Lima J.A., Jenny N.S., Budoff M.J., et al. Soluble intercellular adhesion molecule-1 (sICAM-1) and aortic valve calcification in the multi-ethnic study of atherosclerosis (MESA). The Journal of Heart Valve Disease 2008, 17:388-395.
68. Simionescu A., Simionescu D.T., Vyavahare N.R. Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification. American Journal of Pathology 2007, 171:116-123.
69. Sorescu G.P., Song H., Tressel S.L., et al. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circulation Research 2004, 95:773-779.
70. Steitz S.A., Speer M.Y., Curinga G., et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circulation Research 2001, 89:1147-1154.
71. Stewart B.F., Siscovick D., Lind B.K., et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. Journal of the American College of Cardiology 1997, 29:630-634.
72. Sucosky P., Balachandran K., Elhammali A., Jo H., Yoganathan A.P. Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGF-beta1-dependent pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 2009, 29:254-260.
73. Tintut Y., Patel J., Territo M., Saini T., Parhami F., Demer L.L. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation 2002, 105:650-655.
74. Towler D.A. Oxidation, inflammation, and aortic valve calcification peroxide paves an osteogenic path. Journal of the American College of Cardiology 2008, 52:851-854.
75. Towler D.A., Demer L.L. Thematic series on the pathobiology of vascular calcification: an introduction. Circulation Research 2011, 108:1378-1380.
76. van Tilborg G.A., Vucic E., Strijkers G.J., et al. Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques. Bioconjugate Chemistry 2010, 21:1794-1803.
77. Vengrenyuk Y., Carlier S., Xanthos S., et al. A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps. Proceedings of the National Academy of Sciences, USA 2006, 103:14678-14683.
78. Virmani R., Burke A.P., Farb A., Kolodgie F.D. Pathology of the vulnerable plaque. Journal of the American College of Cardiology 2006, 47(8 Suppl.):C13-C18.
79. Watson K.E., Bostrom K., Ravindranath R., Lam T., Norton B., Demer L.L. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. Journal of Clinical Investigation 1994, 93:2106-2113.